Animal models in xenotransplantation

Expert Opinion on Investigational Drugs

Volumn 9, Issue 9, 2000, Pages 2051-2068

  Zhang, Z ^a   Bedard, E ^a   Luo, Y ^a   Wang, H ^a   Deng, S ^a   Kelvin, D ^a   Zhong, R ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Animal; Baboon; Monkey; Mouse; Pig; Primate; Rat; Rejection; Transplant; Xenotransplantation

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ANIMAL MODEL; CARTILAGE; COMMERCIAL PHENOMENA; ETHICS; EXPERIMENTAL ANIMAL; GRAFT REJECTION; GUINEA PIG; HAMSTER; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; MEDICAL RESEARCH; MONKEY; MOUSE; NONHUMAN; ORGAN DONOR; PHYSIOLOGY; PRIMATE; RABBIT; RAT; REVIEW; RODENT; SWINE; XENOTRANSPLANTATION; ZOONOSIS;

EID: 0033860918     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.9.2051     Document Type: Review

References (132)

1. Transplantation tolerance
2. Transplantation of discordant xenografts: A challenge revisited
3. Xenotransplantation set to resume
4. Human natural anti-α-galactosyl IgG. II. The specific recognition of alpha (1-3)-linked galactose residues
5. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model
6. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humans
7. Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man
8. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
9. Delayed xenograft rejection
10. Acute vascular rejection
11. Suppression of delayed xenograft rejection by specific depletion of elicited antibodies of the IgM isotype
12. Life-supporting pig-to-baboon heart xenotransplantation
13. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition
14. The T-cell response to xenografts: Molecular interactions and graft-specific immunosuppression
15. Chronic rejection of concordant aortic xenografts in the hamster-to-rat model
16. High-affinity anti-Gal immunoglobulin G in chronic rejection of xenografts
17. Prolonged survival of a discordant cardiac xenograft in a rhesus monkey
18. Accommodation of xenografts: A concept revisited
19. Organ transplantation between widely disparate species
20. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model
21. The mechanism of discordant xenograft rejection
22. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts
23. Analysis of rejection mechanism in the rat to mouse cardiac xenotransplantation. Role and characteristics of anti-endothelial cell antibodies
24. Manipulation of xenogeneic skin and/or renal graft survival in the rat-mouse concordant combination by portal vein pretransplant transfusion
25. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB
26. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model
27. Early histopathology of small intestinal discordant xenografts
28. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts
29. The role of natural IgM in the hyperacute rejection of discordant heart xenografts
30. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts
31. Basic anatomical and physiological differences between species should be considered when choosing combinations for use in models of hepatic xenotransplantation: An investigation of the guinea pig-to-rat combination
32. Mouse-to-rabbit xenotransplantation: A new small animal model of hyperacute rejection mediated by the classical complement pathway
33. Analysis of rejection in a novel guinea pig-to-mouse discordant transplant model
34. Novel mouse models for xenotransplantation research
35. Rat-to-mouse small bowel xenotransplantation: A novel model for studying acute vascular and hyperacute xenograft rejection and xenogenic cell migration
36. Long-term survival of hamster hearts in presensitized rats
37. The α-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation
38. Oocyte Gal α 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse
39. Anti-Gal antibody-mediated allograft rejection in α1,3-galactosyltransferase gene knockout mice: A model of delayed xenograft rejection
40. Anti-Gal antibody production in α1,3galactosyl-transferase gene knockout (GT-KO mice after xeno (LEW rat)-and allo (C3H)-transplantation
41. A murine model of antibody-mediated hyperacute rejection by galactose-α(1,3)galactose antibodies in Gal o/o mice
42. Adult and neonatal anti-Gal response in knock-out mice for α1,3galactosyltransferase
43. Differential expression of the α-Gal epitopes on pig and mouse organs
44. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production
45. Evidence for a primarily humoral rejection mechanism in concordant xenogeneic heart transplantation. A sequential immunohistological study in a hamster-to-rat model
46. Immunobiology of the xenograft response: Xenograft rejection in immunodeficient animals
47. Both concordant and discordant heart xenografts are rejected by athymic(nude) rats with the same tempo as in T cell competent animals
48. Natural killer cell-and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses
49. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs
50. Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion and complement inhibition
51. Effect of leflunomide, cyclosporine and splenectomy in two different organ systems of concordant xenotransplantation in rats
52. Experimental concordant xenografting in small animals in organ transplantation in rats and mice
53. Successful retransplantation of mouse-to-rat cardiac xenografts under immunosuppressive monotheraphy with cyclosporine
54. Major histocompatibility complex class I-independent killing of xenogeneic targets by rat allospecific natural killer cells
55. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion
56. Direct antigen presentation through binding of donor intercellular adhesion molecule-1 to recipient lymphocyte function-associated antigen-1 molecules in xenograft rejection
57. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection
58. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse
59. Pig but not human interferon-γ initiates human cell-mediated rejection of pig tissue in vivo
60. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin
61. Long-term survival and functional tolerance of baboon to monkey kidney and liver transplantation: A preliminary report
62. Transplant aspiration cytology for monitoring of kidney xenograft (wolf-dog) under cyclosporine a treatment
63. Delayed hyperacute xenograft rejection in porcine to canine fetal liver transplantation
64. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors
65. Intravenous synthetic alphaGal saccharides delay hyperacute rejection following pig-to-baboon heart transplantation
66. Prolongation of pig-to-dog xenograft survival by modification of the inflammatory mediator response
67. Primates
68. Experimental concordant kidney xenotransplantation in primates
69. Transplantation tolerance following total lymphoid irradiation in baboon-to-vervet monkey kidney xenotransplantation
70. Orthotopic heart transplantation in a transgenic pig-to-primate model
71. Discordant organ xenotransplantation in primates - World experience and current status
72. hDAG transgenic pig organs: Are they concordant for human transplantation?
73. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model
74. Complement-mediated pulmonary xenograft injury: Studies in swine-to-primate orthotopic single lung transplant models
75. Pig xenogeneic antigen modification with green coffee bean alpha-galactosidase
76. Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection
77. Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection
78. Porcine cartilage transplants in the cynomolgus monkey III. Transplantation of alpha-galactosidase-treated porcine cartilage
79. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection
80. Extracorporeal liver perfusion system for successful hepatic support pending liver regeneration or liver transplantation: A pre-clinical controlled trial
81. Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS
82. Transgenic human decay accelerating factor makes normal pigs function as a concordant species
83. Successful application of extracorporeal liver perfusion: A technology whose time has come
84. Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure
85. Assessment of hyperacute rejection in a rat-to-primate cardiac xenograft model
86. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates
87. Man, apes and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells
88. Transgenic strategies
89. Effect of transgenic expression of human decay accelerating factor on the inhibition of hyperacute rejection of pig organs
90. Improved renal function and fewer rejection episodes using SDZ RAD in life-supporting hDAF pig to primate renal xenotransplantation
91. Mycophenolic acid-sodium (ERL080) permits prolonged function in hDAF pig to primate renal xenotransplantation
92. Transgenic pig hearts and kidneys expressing human CD59, CD55, or CD46 are protected from hyperacute rejection upon transplantation into baboons
93. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants
94. Prolonged survival of orthotopic cardiac xenografts in a hDAF transgenic pig-to-baboon model
95. Complement inactivation with an anti-C5 monoclonal antibody prevents hyperacute rejection in a presensitized rat to mouse heart transplant model
96. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts
97. Transplantation of porcine fetal pancreas to diabetic patients
98. Extracorporeal liver perfusion system for successful hepatic support pending liver regeneration or liver transplantation: A pre-clinical controlled trial
99. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease
100. Ontogenesis of embryonic porcine ventral mesencephalon in the perspective of its potential use as a xenograft in Parkinson's disease
101. Expression of Gal α(1,3)gal on neonatal porcine islet β-cells and susceptibility to human antibody/complement lysis
102. Intact pancreatic islet function despite humoral xenorecognition in the pig-to-monkey combination
103. Intact pig pancreatic islet function in the presence of human xenoreactive natural antibody binding and complement activation
104. Functional and morphological differentiation of fetal porcine islet-like cell clusters after transplantation into nude mice
105. Transplantation of fetal porcine pancreas to diabetic or normoglycemic nude mice, evidence of a rapid engraftment process demonstrated by blood flow and heat shock protein 70 measurements
106. Discordant cellular xenografts revascularized in intermediate athymic hosts fail to induce a hyperacute rejection when transplanted to immunocompetent rats
107. Prevention of xenograft rejection by masking donor HLA class I antigens
108. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig
109. Evaluation of graft-host response for various tissue sources and animal models
110. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue
111. Cellular rejection of fetal pancreas grafts: Differences between allo- and xenograft rejection
112. Assessment of insulin secretion in vitro from microencapsulated fetal porcine islet-like cell clusters and rat, mouse and human pancreatic islets
113. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression
114. Viability and recovery of frozen-thawed human islets and in vivo quality control by xenotransplantation
115. Large scale isolation, growth and function of porcine neonatal islet cells
116. Isolation of porcine pancreatic islets for xenotransplantation studies: Effects of low collagenase digestion temperatures
117. Reversal of naturally occurring diabetes in primates by unmodified islet xenografts without chronic immunosuppression
118. Efficacy of immunosuppressive drugs in islet xenotransplantation: Leflunomide in combination with cyclosporine and mycophenolate mofetil prevents islet xenograft rejection in the pig-to-rat model
119. Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice
120. Prolonged survival of discordant porcine islet xenografts
121. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres
122. Porcine pancreatic islets: Isolation, microencapsulation and xenotransplantation
123. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes
124. Xenograft rejection of porcine islet-like cell clusters in immunoglobulin- or Fc-receptor gamma-deficient mice
125. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: Analysis of the human immune response against porcine islet transplantation
126. Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice
127. Islet allo- and xenotransplantation in normal, intercellular adhesion molecule-1-deficient and P selectin-deficient mice
128. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice
129. Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: An immunohistochemical study
130. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression